<p><strong>新田株式會社</strong> (TSE:2733) 將於 6 月 8 日支付每股 56.00 日元的股息。這將使年度支付達到股價的 3.7%，高於該行業大多數公司的支付水平。</p>
<p>人工智能即將改變醫療保健。這 20 只股票正在從早期診斷到藥物發現等各個方面進行研發。最棒的是——它們的市值都在 100 億美元以下——現在仍然有機會提前投資。</p>
<h2>新田未來的股息預測似乎得到了盈利的良好支持</h2>
<p>令人印象深刻的股息收益率固然好，但如果支付無法持續，這一點就不太重要。然而，新田的盈利輕鬆覆蓋了股息。因此，其賺取的大部分利潤被重新投資回業務中。</p>
<p>在接下來的一年中，預計每股收益將增長 11.4%。如果股息繼續沿着近期的趨勢發展，我們估計支付比率將為 39%，這在我們認為股息可持續的範圍內。</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/7884402-historic-dividend-1-dark-2/1765063971641?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/7884402-historic-dividend-1-dark-2/1765063971641"/></p>
<p>TSE:2733 歷史股息 2025 年 12 月 6 日</p>
<p>查看我們對新田的最新分析</p>
<h2>股息波動性</h2>
<p>該公司的股息歷史標誌着不穩定，過去 10 年中至少有一次削減。股息從 2015 年的每年 25.00 日元增長到最近的每年 112.00 日元。這意味着公司在此期間以約 16% 的年率增長其分配。儘管股息在這段時間內迅速增長，但由於過去的削減，我們不確定這隻股票在未來是否會成為可靠的收入來源。</p>
<h2>新田可能難以增加股息</h2>
<p>由於股息相對不穩定，更重要的是觀察每股收益是否在增長。然而，新田在過去五年中每股收益僅以每年 4.5% 的速度增長。儘管增長可能微薄，但新田仍然可以支付更高比例的收益以增加股東回報。</p>
<h2>總結</h2>
<p>總體而言，這是一個合理的股息，增加股息是一個額外的好處。儘管支付比率是一個好跡象，但我們對公司的股息記錄並不太熱衷。支付並不出色，但它可能成為股息投資組合的不錯補充。</p>
<p>市場動向證明了穩定的股息政策相比於更不可預測的政策是多麼受到重視。然而，投資者在分析一家公司時需要考慮除了股息支付之外的許多其他因素。例如，我們已經識別出 <strong>新田的一個警示信號</strong>，在投資之前你應該注意。如果你是股息投資者，你可能還想查看我們 <strong>精心挑選的高收益股息股票列表。</strong></p>

2733

<p>新田株式會社（TSE:2733）將於 6 月 8 日支付每股 56.00 日元的股息，年收益率為 3.7%。儘管過去股息波動較大，但目前的收益能夠覆蓋股息支付，預計明年的每股收益將增長 11.4%。預計股息支付比率為 39%，表明其可持續性。然而，新田的股息歷史顯示出不穩定性，儘管快速增長，但過去曾出現過削減股息的情況。投資者在評估該公司時應考慮除股息以外的其他因素</p>

<p><strong>Arata Corporation</strong> (TSE:2733) will pay a dividend of ¥56.00 on the 8th of June. This will take the annual payment to 3.7% of the stock price, which is above what most companies in the industry pay.</p>
<div class="lb-trans"><p><strong>新田株式會社</strong> (TSE:2733) 將於 6 月 8 日支付每股 56.00 日元的股息。這將使年度支付達到股價的 3.7%，高於該行業大多數公司的支付水平。</p>
</div><p>AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.</p>
<div class="lb-trans"><p>人工智能即將改變醫療保健。這 20 只股票正在從早期診斷到藥物發現等各個方面進行研發。最棒的是——它們的市值都在 100 億美元以下——現在仍然有機會提前投資。</p>
</div><h2>Arata's Future Dividend Projections Appear Well Covered By Earnings</h2>
<div class="lb-trans"><h2>新田未來的股息預測似乎得到了盈利的良好支持</h2>
</div><p>Impressive dividend yields are good, but this doesn't matter much if the payments can't be sustained. However, Arata's earnings easily cover the dividend. As a result, a large proportion of what it earned was being reinvested back into the business.</p>
<div class="lb-trans"><p>令人印象深刻的股息收益率固然好，但如果支付無法持續，這一點就不太重要。然而，新田的盈利輕鬆覆蓋了股息。因此，其賺取的大部分利潤被重新投資回業務中。</p>
</div><p>Over the next year, EPS is forecast to expand by 11.4%. If the dividend continues along recent trends, we estimate the payout ratio will be 39%, which is in the range that makes us comfortable with the sustainability of the dividend.</p>
<div class="lb-trans"><p>在接下來的一年中，預計每股收益將增長 11.4%。如果股息繼續沿着近期的趨勢發展，我們估計支付比率將為 39%，這在我們認為股息可持續的範圍內。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/7884402-historic-dividend-1-dark-2/1765063971641" alt="" original-src="https://images.simplywall.st/asset/chart/7884402-historic-dividend-1-dark-2/1765063971641"/></p>
<p>TSE:2733 Historic Dividend December 6th 2025</p>
<div class="lb-trans"><p>TSE:2733 歷史股息 2025 年 12 月 6 日</p>
</div><p>Check out our latest analysis for Arata</p>
<div class="lb-trans"><p>查看我們對新田的最新分析</p>
</div><h2>Dividend Volatility</h2>
<div class="lb-trans"><h2>股息波動性</h2>
</div><p>The company's dividend history has been marked by instability, with at least one cut in the last 10 years. The dividend has gone from an annual total of ¥25.00 in 2015 to the most recent total annual payment of ¥112.00. This implies that the company grew its distributions at a yearly rate of about 16% over that duration. Dividends have grown rapidly over this time, but with cuts in the past we are not certain that this stock will be a reliable source of income in the future.</p>
<div class="lb-trans"><p>該公司的股息歷史標誌着不穩定，過去 10 年中至少有一次削減。股息從 2015 年的每年 25.00 日元增長到最近的每年 112.00 日元。這意味着公司在此期間以約 16% 的年率增長其分配。儘管股息在這段時間內迅速增長，但由於過去的削減，我們不確定這隻股票在未來是否會成為可靠的收入來源。</p>
</div><h2>Arata May Find It Hard To Grow The Dividend</h2>
<div class="lb-trans"><h2>新田可能難以增加股息</h2>
</div><p>With a relatively unstable dividend, it's even more important to see if earnings per share is growing. However, Arata has only grown its earnings per share at 4.5% per annum over the past five years. While growth may be thin on the ground, Arata could always pay out a higher proportion of earnings to increase shareholder returns.</p>
<div class="lb-trans"><p>由於股息相對不穩定，更重要的是觀察每股收益是否在增長。然而，新田在過去五年中每股收益僅以每年 4.5% 的速度增長。儘管增長可能微薄，但新田仍然可以支付更高比例的收益以增加股東回報。</p>
</div><h2>In Summary</h2>
<div class="lb-trans"><h2>總結</h2>
</div><p>Overall, this is a reasonable dividend, and it being raised is an added bonus. While the payout ratios are a good sign, we are less enthusiastic about the company's dividend record. The payment isn't stellar, but it could make a decent addition to a dividend portfolio.</p>
<div class="lb-trans"><p>總體而言，這是一個合理的股息，增加股息是一個額外的好處。儘管支付比率是一個好跡象，但我們對公司的股息記錄並不太熱衷。支付並不出色，但它可能成為股息投資組合的不錯補充。</p>
</div><p>Market movements attest to how highly valued a consistent dividend policy is compared to one which is more unpredictable. Still, investors need to consider a host of other factors, apart from dividend payments, when analysing a company. As an example, we've identified <strong>1 warning sign for Arata</strong> that you should be aware of before investing. If you are a dividend investor, you might also want to look at our <strong>curated list of high yield dividend stocks.</strong></p>
<div class="lb-trans"><p>市場動向證明了穩定的股息政策相比於更不可預測的政策是多麼受到重視。然而，投資者在分析一家公司時需要考慮除了股息支付之外的許多其他因素。例如，我們已經識別出 <strong>新田的一個警示信號</strong>，在投資之前你應該注意。如果你是股息投資者，你可能還想查看我們 <strong>精心挑選的高收益股息股票列表。</strong></p>
</div>

Arata（TSE:2733）將派發每股 56.00 日元的股息